Shattuck Labs, Inc.
Total Trades
10
Buys
8
Sells
1
Largest Trade
N/A
Insiders
6
Institutional Funds
43
Inst. Value
$1M+
Activist Filings
22
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 6.3M | $0.87 | Sep 3, 2025 |
| Ashiya Mona | Director | BUY | $1M+ | 6.3M | $0.87 | Sep 3, 2025 |
| Schreiber Taylor | CEO | BUY | $15K–$50K | 37K | $1.21 | Oct 8, 2024 |
| Brous Tyler | Director | BUY | $15K–$50K | 8K | $3.89 | Jul 1, 2024 |
| Schreiber Taylor | CEO | BUY | $50K–$100K | 14K | $3.47 | Jun 26, 2024 |
| Neill Andrew R | CFO | SELL | $100K–$500K | 25K | $10.00 | Jan 16, 2024 |
| Neill Andrew R | CFO | GRANT | N/A | 57K | — | Jan 16, 2024 |
| Golumbeski George | Director | BUY | $100K–$500K | 28K | $3.63 | Apr 27, 2022 |
| Golumbeski George | Director | BUY | $50K–$100K | 26K | $3.69 | Apr 26, 2022 |
| Brous Tyler | Director | BUY | $50K–$100K | 8K | $7.00 | Jan 20, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 43 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| PIPER SANDLER & CO. | 39K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 6.3M | $1M+ | SH |
| Redmile Group, LLC | 5.5M | $1M+ | SH |
| NEXTBio Capital Management LP | 3.1M | $1M+ | SH |
| Prosight Management, LP | 2.4M | $1M+ | SH |
| CLARK ESTATES INC/NY | 1.5M | $1M+ | SH |
| PINNACLE ASSOCIATES LTD | 1.4M | $1M+ | SH |
| Point72 Asset Management, L.P. | 1.1M | $1M+ | SH |
| Aberdeen Group plc | 531K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 496K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 341K | $1M+ | SH |
| TD ASSET MANAGEMENT INC | 251K | $500K+ | SH |
| STATE STREET CORP | 215K | $500K+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 195K | $500K+ | SH |
| Pathstone Holdings, LLC | 157K | $500K+ | SH |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 135K | $100K–$500K | SH |
| GOLDMAN SACHS GROUP INC | 128K | $100K–$500K | SH |
| Bank of New York Mellon Corp | 105K | $100K–$500K | SH |
| LBJ Family Wealth Advisors, Ltd. | 82K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 79K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
T. Rowe Price Investment Management, Inc.
SC 13G · Feb 6, 2026
11.7%
7.4M shares
SC 13G/A · Nov 14, 2025
9.9%
6.5M shares
SC 13D · Sep 3, 2025
10.0%
6.3M shares
SC 13D/A · Aug 26, 2025
9.9%
6.4M shares
SC 13D/A · Aug 7, 2025
11.8%
5.7M shares
SC 13G/A · Jul 29, 2025
4.5%
2.1M shares
SC 13G/A · Jul 16, 2025
1.8%
879K shares
Adage Capital Management, L.P.
SC 13G/A · Feb 12, 2025
9.8%
4.7M shares
SC 13D/A · Dec 7, 2024
11.8%
5.6M shares
SC 13G/A · Nov 13, 2024
14.0%
6.7M shares
SC 13G/A · Nov 12, 2024
5.0%
2.4M shares
SC 13G · Nov 8, 2024
5.5%
2.6M shares
SC 13G/A · Nov 7, 2024
0.3%
135K shares
SC 13G/A · Nov 4, 2024
5.0%
2.4M shares
SC 13G · Oct 24, 2024
5.5%
2.6M shares
SC 13G/A · Aug 16, 2024
11.3%
5.4M shares
SC 13G · Jan 29, 2024
5.5%
2.6M shares
SC 13G · Dec 29, 2023
5.9%
2.8M shares
SC 13D/A · Dec 26, 2023
12.0%
5.7M shares
SC 13G · Jun 9, 2022
5.0%
2.1M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
Takeda Pharmaceutical Company Limited
SC 13G/A · Jan 14, 2022
5.0%
2.1M shares